HighTower Advisors
HAE icon

HighTower Advisors’s Haemonetics HAE Stock Holding History

HighTower Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Sell
18,378
-1,904
-9% -$122K ﹤0.01% 2033
2026
Q1 		$1.14M Buy
20,282
+2,640
+15% +$172K ﹤0.01% 2093
2025
Q4 		$1.41M Buy
17,642
+472
+3% +$31.7K ﹤0.01% 1889
2025
Q3 		$837K Sell
17,170
-2,553
-13% -$158K ﹤0.01% 2226
2025
Q2 		$1.47M Buy
19,723
+16,459
+504% +$1.09M ﹤0.01% 1760
2025
Q1 		$207K Sell
3,264
-89
-3% -$6.05K ﹤0.01% 3156
2024
Q4 		$262K Buy
3,353
+244
+8% +$19.6K ﹤0.01% 2995
2024
Q3 		$248K Sell
3,109
-556
-15% -$44.9K ﹤0.01% 2963
2024
Q2 		$298K Buy
3,665
+799
+28% +$70.3K ﹤0.01% 2720
2024
Q1 		$242K Sell
2,866
-1,591
-36% -$125K ﹤0.01% 2850
2023
Q4 		$384K Buy
4,457
+537
+14% +$46.4K ﹤0.01% 2518
2023
Q3 		$351K Buy
+3,920
New +$350K ﹤0.01% 2470
2021
Q1 		– Sell
-4,836
Closed -$573K – 3143
2020
Q4 		$573K Buy
+4,836
New +$521K ﹤0.01% 1580
2016
Q2 		– Sell
-8,528
Closed -$299K – 1877
2016
Q1 		$299K Sell
8,528
-528
-6% -$17.1K ﹤0.01% 1611
2015
Q4 		$290K Buy
+9,056
New +$294K ﹤0.01% 1586

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HighTower Advisors's HAE Position: Q2 2026 in Review

HighTower Advisors reduced its Haemonetics (HAE) stake by 9.4% in Q2 2026, selling an estimated $122K and leaving 18,378 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2033.

HighTower Advisors first reported a position in HAE in Q4 2015 and has held it in 15 quarters since. The position peaked at $1.47M in Q2 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • HighTower Advisors held 18,378 shares of Haemonetics worth $1.38M as of Q2 2026.
  • HighTower Advisors sold 1,904 Haemonetics shares in Q2 2026, an estimated $122K.
  • Haemonetics made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2033 holding.
  • HighTower Advisors first reported a position in Haemonetics in Q4 2015 and has held it in 15 quarters since.
  • HighTower Advisors's Haemonetics position peaked at $1.47M in Q2 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.